Authors:
Horino, K
Kindezelskii, AL
Elner, VM
Hughes, BA
Petty, HR
Citation: K. Horino et al., Tumor cell invasion of model 3-dimensional matrices: demonstration of migratory pathways, collagen disruption, and intercellular cooperation, FASEB J, 15(6), 2001, pp. 932-939
Authors:
Shimura, M
Yuan, YK
Chang, JHT
Zhang, SY
Campochiaro, PA
Zack, DJ
Hughes, BA
Citation: M. Shimura et al., Expression and permeation properties of the K+ channel Kir7.1 in the retinal pigment epithelium, J PHYSL LON, 531(2), 2001, pp. 329-346
Authors:
Hughes, BA
Kumar, G
Yuan, Y
Swaminathan, A
Yan, D
Sharma, A
Plumley, L
Yang-Feng, TL
Swaroop, A
Citation: Ba. Hughes et al., Cloning and functional expression of human retinal Kir2.4, a pH-sensitive inwardly rectifying K+ channel, AM J P-CELL, 279(3), 2000, pp. C771-C784
Authors:
Yang, DL
Sun, F
Thomas, LL
Offord, J
MacCallum, DK
Dawson, DC
Hughes, BA
Ernst, SA
Citation: Dl. Yang et al., Molecular cloning and expression of an inwardly rectifying K+ channel frombovine corneal endothelial cells, INV OPHTH V, 41(10), 2000, pp. 2936-2944
Authors:
Ren, JM
Shin, DH
Chung, HS
Birt, CM
Glover, BK
Juzych, MS
Hughes, BA
Kim, C
Citation: Jm. Ren et al., Efficacy of apraclonidine 1% versus pilocarpine 4% for prophylaxis of intraocular pressure spike after argon laser trabeculoplasty, OPHTHALMOL, 106(6), 1999, pp. 1135-1139
Authors:
Shin, DH
McCracken, MS
Bendel, RE
Pearlman, R
Juzych, MS
Hughes, BA
Schulz, LL
Kim, C
Baek, NH
Citation: Dh. Shin et al., The additive effect of latanoprost to maximum-tolerated medications with low-dose, high-dose, or no pilocarpine therapy, OPHTHALMOL, 106(2), 1999, pp. 386-390
Authors:
Gallagher, A
White, JV
Reeves, RS
Edge, MS
Tate, MH
Gee, M
Fiedler, KM
Hughes, BA
Laramee, SH
Russell, C
Williams, EG
Flik, JA
Kellie, SE
Fitz, PA
Ross, JK
Cobb, K
Rivera, CL
Citation: A. Gallagher et al., The Future is Now - Dietetics 2000 presenting ADA's 1999-2000 Board of Directors, J AM DIET A, 99(6), 1999, pp. 752-755